-
Mashup Score: 1
The findings, published in The Lancet Oncology, hint at a new frontier in the fight against some of the deadliest forms of cancer—with one patient seeing their tumours vanish entirely for over two years.
Source: www.businesstoday.inCategories: General Medicine NewsTweet
-
Mashup Score: 1Exposure to toxin increases colorectal cancer risk among younger adults, study finds - 15 day(s) ago
Amid the alarming trend of colorectal cancer cases rising among young people, a new study has linked a bacterial toxin called colibactin to the increase in early-onset cases.
Source: www.foxnews.comCategories: General Medicine NewsTweet-
@RenoHemonc @chadinabhan @ShrutiPatelMD Good ask @RenoHemonc - we taped this before the article was published but I did comment on the colibactin @Nature publication in this feature that came out last week. So much more to learn… https://t.co/KRsV2ZdJtV @ShaalanBeg @ShrutiPatelMD @chadinabhan
-
-
Mashup Score: 16Gene-editing therapy shows early success in fighting advanced gastrointestinal cancers - 16 day(s) ago
Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. …
Source: medicalxpress.comCategories: General Medicine NewsTweet-
Gene-editing therapy shows early success in fighting advanced gastrointestinal cancers https://t.co/oAEgilP6Au via @medical_xpress
-
-
Mashup Score: 17
/PRNewswire/ — Intima Bioscience, a clinical stage oncology company focused on curative intent in solid tumor cancers, presented data from a first-in-human…
Source: www.prnewswire.comCategories: General Medicine NewsTweet-
#PressRelease via @PRNewswire on Data from First-in-Human Trial targeting CISH, a Novel Immune Checkpoint, in Patients with Metastatic Colorectal Colorectal Cancer - trial results presented April 29 at @AACR #AACR25 https://t.co/z03eIWb5ov #crcsm #CRISPR #coloncancer #CISH
-
-
Mashup Score: 2Cancer survivor grateful for 'lifesaving' clinical trial, as doctors are wary over future funding - 18 day(s) ago
A Stage 4 cancer survivor is grateful for a ‘lifesaving’ clinical trial, but experts are wary over potential federal funding cuts.
Source: www.nbcchicago.comCategories: General Medicine NewsTweet-
RT @nbcchicago: Cancer survivor grateful for 'lifesaving' clinical trial, as doctors are wary over future funding https://t.co/AG7M5M7AIM
-
-
Mashup Score: 21Woman, 36, with Stage 4, incurable colon cancer now cancer-free thanks to new treatment - 18 day(s) ago
Emma Weston joined the clinical trial after running out of treatment options. For two years, she’s been cancer free.
Source: www.today.comCategories: General Medicine NewsTweet-
Woman, 36, with Stage 4, incurable colon cancer now cancer-free thanks to new treatment https://t.co/kGEy8yZ4NA via @TODAYshow --- Results presented at #AACR25 @AACR April 29, 2025
-
-
Mashup Score: 10Cancer survivor grateful for 'lifesaving' clinical trial, as doctors are wary over future funding - 18 day(s) ago
A Stage 4 cancer survivor is grateful for a ‘lifesaving’ clinical trial, but experts are wary over potential federal funding cuts.
Source: www.nbcchicago.comCategories: General Medicine NewsTweet-
Cancer survivor grateful for ‘lifesaving' clinical trial as funding cuts loom - @nbcchicago @kchappellnews https://t.co/kcQILxLd1N #AACR25 @AACRPres @AACR @AACR_CEO
-
-
Mashup Score: 3The Role of Social Media in Fueling Bias in Oncology - 19 day(s) ago
This Viewpoint explores the role of social media in the dissemination of medical research findings and discusses how oversight, education, and media literacy can help prevent the spread of misinformation.
Source: jamanetwork.comCategories: General Medicine NewsTweet-
.@oncoblogger @JAMAOnc @fotiosloupakis I am trying to stir debate, as there should be on this and many other topics. Am I doing it right? 😆 https://t.co/7WaBddjtuK
-
-
Mashup Score: 9AACR 2025 Annual Meeting Guide - 22 day(s) ago
Carry the AACR Annual Meeting 2025 with you wherever you go. All app content and functions (including abstracts) can be accessed without an Internet connection. Search and browse presenters, sessions, and exhibitors to create a personal itinerary.
Source: eppro02.ativ.meCategories: General Medicine NewsTweet-
Abstract drop via the #AACR25 @AACR meetings app: CT269 - First-in-human trial in patients with metastatic colorectal cancer using CRISPR-engineered tumor infiltrating lymphocytes in which the intracellular immune checkpoint CISH is inhibited https://t.co/ButUq645wW #AACR25 https://t.co/l8aeYYbj1c
-
-
Mashup Score: 8Program Guide – ASCO Meeting Program Guide - 25 day(s) ago
Presenter: Rui-Hua Xu, MD, PhD Presenter: Aaron Elliott Lisberg, MD Presenter: Silver Alkhafaji, BS Discussant: Emil Lou, MD, PhD Discussant: Lillian L. Siu, MD, FASCO, FRCPC Presenter: Jaume Capdevila, MD, PhD Presenter: Tadayoshi Hashimoto, MD, PhD Presenter: Thorvardur Ragnar Halfdanarson, MD Discussant: Heloisa P. Soares,
Source: meetings.asco.orgCategories: General Medicine NewsTweet-
For easy access to today's announced list for the #ASCO25 Developmental Therapeutics-Molecularly Targeted Agents and Tumor Biology Oral Abstract Session: https://t.co/Fd2SyUfPo0 https://t.co/0k0hAn6Bhn
-
Massive breakthrough Geneedited immune cells halt growth of stage IV gastrointestinal cancers in trial patients https://t.co/Ogimgvya88 via @business_today